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An 80-year-old female presented to the emergency de-partment with complaints of chest and abdominal pain,
diffuse myalgia, and generalized weakness. Her past medical
history was notable for hypertension, non-insulin–dependent
diabetes mellitus, and gastro-esophageal reflux disease. She
was afebrile and abdominal examination revealed tenderness to
palpation in the right upper quadrant. Laboratory examination
confirmed leukocytosis (16,500/mm3) and hemoconcentration
(hematocrit, 42.1%) with normal liver chemistry tests. Isotonic
crystalloid fluid resuscitation was initiated. Initial chest radio-
graph demonstrated an elevated right hemidiaphragm and
right lower lobe atelectasis or pneumonia. Subsequently, em-
piric intravenous antibiotics (ceftriaxone and azithromycin)
were initiated for community-acquired pneumonia.
A computed tomography scan of the abdomen (Fig. 1)
revealed emphysematous cholecystitis with possible gallbladder
FIG. 1. Computed tomography of emphysematous cholecystitis (arrow). Circumferential mural emphysema involving the
gallbladder, which contains multiple gallstones. There is extension of inflammation into the adjacent liver with a small oblong
fluid collection measuring 19· 8 mm reflecting an intrahepatic abscess. Inflammation containing gas measuring 3 · 2 cm
between the gallbladder and liver may reflect a site of perforation. There are a few locules of extraluminal gas seen within the
right upper quadrant. Inflammation extends along the right paracolic gutter and medially to the pancreas.
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perforation. Intravenous metronidazole was added to the
empiric antibiotic regimen. The patient developed atrial
fibrillation with rapid ventricular response in the emergency
department, which required pharmacologic management and
admission to the intensive care unit. Due to hemodynamic
instability, initial source control was achieved with a percu-
taneous cholecystostomy, and 40 mL of brown foul-smelling
drainage was aspirated from the gallbladder. Empiric anti-
biotics were changed to meropenem and vancomycin. Blood
and bile cultures were positive for two isolates of Clostridium
perfringens and bile culture also was positive for Enterococcus
faecium (sensitive to ampicillin and vancomycin).
The patient failed to improve, exhibiting persistent ab-
dominal pain and leukocytosis, and open cholecystectomy
was required for definitive source control. At surgery, the
omentum encased the gallbladder containing the perforation,
and dense inflammatory adhesions to the colon and duode-
num required adhesiolysis. Pathology of the surgical specimen
(Fig. 2) revealed histologic evidence of acute gangrenous cho-
lecystitis with cholelithiasis and a transmural scar indicating
previous ulcerating disease. She was discharged home on
post-operative day 4 with an oral course of metronidazole
(500 mg PO QID·7 d) to complete two weeks of antimicrobial
therapy for C. perfringens bacteremia. It was confirmed on
subsequent clinic visits that she recovered fully with no recur-
rence of abdominal infection.
Emphysematous cholecystitis is characterized by the
presence of gas within the wall or lumen of the gallbladder in
the absence of an abnormal biliary-enteric communication.
The pathophysiology is an acute infection caused by gas-
producing organisms with local ischemia. It was first de-
scribed by Stolz in 1901 in three patients at post-mortem ex-
amination [1]. The first pre-operative diagnosis was made by
C.F. Hegner in 1931 with abdominal radiographs in a 62-year-
old male who underwent cholecystectomy but died of a pul-
monary embolus on the fourth post-operative day [2].
Although the condition is relatively rare, it is of great
importance to surgeons as the reported mortality rate is
high (15%–20%) [3] and the standard treatment is emer-
gency cholecystectomy, with percutaneous drainage reserved
for patients not stable for surgical intervention [4–6]. Early
diagnosis is necessary. However, it is difficult to differentiate
FIG. 2. (A) Histologic evidence of acute gangrenous emphysematous cholecystitis. 20·magnification. Acute gangrenous
cholecystitis with full-thickness involvement of the gallbladder wall, and a transmural scar. (B) Histologic evidence of acute
gangrenous emphysematous cholecystitis. 400 ·magnification. Higher magnification image demonstrates that the inflam-
matory infiltrate is composed primarily of neutrophils.
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typical acute cholecystitis from emphysematous cholecystitis
based on clinical presentation; radiologic imaging (abdominal
radiograph, ultrasound, computed tomography) is required.
Early surgical intervention may precede development of
gangrenous cholecystitis and perforation, thereby greatly re-
ducing mortality in this population [7].
Unlike acute cholecystitis, which is more frequent in fe-
males, emphysematous cholecystitis is more frequent in males
(male-female ratio, 4:1), many of whom have diabetes mellitus
[8]. The causative pathogens in emphysematous cholecystitis
are gas-producing bacteria (e.g., C. perfringens, Escherichia coli,
Klebsiella spp.) with a high rate of concomitant bacteremia.
Early initiation of empiric broad-spectrum empiric antibiotics
to cover these pathogens is required for successful outcome.
Bile and blood cultures are necessary to provide pathogen-
directed antimicrobial therapy. The recommended duration
of antimicrobial therapy is longer (two weeks recommended)
if bacteremia is present.
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